Silvia Gold

652 total citations
10 papers, 236 citations indexed

About

Silvia Gold is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Silvia Gold has authored 10 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Infectious Diseases. Recurrent topics in Silvia Gold's work include Trypanosoma species research and implications (4 papers), Parasitic Diseases Research and Treatment (3 papers) and Helminth infection and control (3 papers). Silvia Gold is often cited by papers focused on Trypanosoma species research and implications (4 papers), Parasitic Diseases Research and Treatment (3 papers) and Helminth infection and control (3 papers). Silvia Gold collaborates with scholars based in Argentina, Spain and United States. Silvia Gold's co-authors include Alejandro Krolewiecki, Roberto Gómez, Daniel E. Gómez, Marcelo D. Guthmann, Mariano R. Gabri, Luis E. Fernández, Daniel F. Alonso, Leonardo Fainboim, José Muñóz and Enrico Colli and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmaceutical Sciences and BMC Public Health.

In The Last Decade

Silvia Gold

10 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvia Gold Argentina 8 85 64 60 44 44 10 236
Marcos J. Ramos-Benítez Puerto Rico 7 46 0.5× 58 0.9× 54 0.9× 58 1.3× 24 0.5× 24 202
Rajesh M. Valanparambil Canada 6 101 1.2× 31 0.5× 33 0.6× 67 1.5× 20 0.5× 9 205
Cristian R. Falcón Argentina 10 131 1.5× 38 0.6× 60 1.0× 138 3.1× 19 0.4× 13 311
Koji Furuya Japan 13 257 3.0× 84 1.3× 67 1.1× 19 0.4× 19 0.4× 33 435
Asma Al-Thani Qatar 10 43 0.5× 79 1.2× 71 1.2× 24 0.5× 38 0.9× 19 269
Eda Patricia Tenorio Mexico 11 108 1.3× 41 0.6× 83 1.4× 168 3.8× 72 1.6× 18 335
Franziska Muscate Germany 6 37 0.4× 51 0.8× 44 0.7× 85 1.9× 27 0.6× 8 225
Lindsey E. Cook United States 6 33 0.4× 120 1.9× 44 0.7× 124 2.8× 32 0.7× 6 320
Alvaro Baeza Garcia United States 8 75 0.9× 39 0.6× 73 1.2× 203 4.6× 22 0.5× 10 346
David Carey United States 9 200 2.4× 57 0.9× 63 1.1× 43 1.0× 32 0.7× 12 380

Countries citing papers authored by Silvia Gold

Since Specialization
Citations

This map shows the geographic impact of Silvia Gold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Gold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Gold more than expected).

Fields of papers citing papers by Silvia Gold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Gold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Gold. The network helps show where Silvia Gold may publish in the future.

Co-authorship network of co-authors of Silvia Gold

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Gold. A scholar is included among the top collaborators of Silvia Gold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Gold. Silvia Gold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gold, Silvia, et al.. (2023). Mother‐to‐child Chagas disease transmission: The challenge of detection and prevention in areas without the risk of vectorial transmission. International Journal of Gynecology & Obstetrics. 164(3). 835–842. 4 indexed citations
3.
Errecalde, Jorge Oscar, A. Lifschitz, Laura Ceballos, et al.. (2021). Safety and Pharmacokinetic Assessments of a Novel Ivermectin Nasal Spray Formulation in a Pig Model. Journal of Pharmaceutical Sciences. 110(6). 2501–2507. 18 indexed citations
4.
Pereiro, Ana Cristina & Silvia Gold. (2019). Building an innovative Chagas disease program for primary care units, in an urban non- endemic city. BMC Public Health. 19(1). 904–904. 7 indexed citations
5.
Pereiro, Ana Cristina, et al.. (2018). Reporting of adverse reactions to benznidazole: does medical expertise matter?. Revista Panamericana de Salud Pública. 42. 1–8. 4 indexed citations
6.
Muñóz, José, María Rosa Ballester, Rosa María Antonijoan, et al.. (2018). Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers. PLoS neglected tropical diseases. 12(1). e0006020–e0006020. 56 indexed citations
7.
Echazú, Adriana, Marisa Juaréz, Paola A. Vargas, et al.. (2017). Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: A community-based pragmatic study. PLoS neglected tropical diseases. 11(10). e0006003–e0006003. 45 indexed citations
8.
Wiens, Matthew O., Steve Kanters, Edward Mills, et al.. (2016). Systematic Review and Meta-analysis of the Pharmacokinetics of Benznidazole in the Treatment of Chagas Disease. Antimicrobial Agents and Chemotherapy. 60(12). 7035–7042. 13 indexed citations
9.
Fernández, Luis E., Mariano R. Gabri, Marcelo D. Guthmann, et al.. (2010). NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines. Journal of Immunology Research. 2010(1). 814397–814397. 69 indexed citations
10.
Cerio, R., Silvia Gold, & E. Wilson Jones. (1991). White fibrous papulosis of the neck. Clinical and Experimental Dermatology. 16(3). 224–225. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026